Jacob Prince, Singh Swati, Bhavani Gandham SriLakshmi, Gowrishankar Kalpana, Narayanan Dhanya Lakshmi, Nampoothiri Sheela, Patil S J, Soni J P, Muranjan Mamta, Kapoor Seema, Dhingra Bhavna, Bhat Ballambattu Vishnu, Bajaj Shruti, Banerjee Amrita, Mamadapur Mahabaleshwar, Hariharan Sankar V, Kamath Nutan, Shenoy Rathika D, Suri Deepti, Shukla Anju, Dalal Ashwin, Phadke Shubha R, Nishimura Gen, Mortier Geert, Shah Hitesh, Girisha Katta M
Department of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India.
Department of Medical Genetics, Apollo Children's Hospitals, Chennai, India.
Eur J Hum Genet. 2025 May;33(5):607-613. doi: 10.1038/s41431-024-01776-8. Epub 2024 Dec 20.
Skeletal dysplasias are a clinically and genetically heterogeneous group of rare disorders. Studies from large cohorts are essential to provide insights into the disease epidemiology, phenotypic spectrum, and mutational profiles. Here we enumerate additional 248 Indians from 197 families with a skeletal dysplasia, following a similar study earlier. We achieved a clinical-molecular diagnosis in 145 families by targeted analysis in 37 and next generation sequencing (exomes and genomes) in 108 families that resulted in a diagnostic yield of 73.6% (145 of 197 families). We identified 149 causal variants, of which 85 were novel, across 73 genes. Eighty-one distinct monogenic forms of skeletal dysplasia were observed with a high proportion of autosomal recessive skeletal dysplasias (60%, 84 families). We observed consanguinity in 35% of the families. Lysosomal storage diseases with skeletal involvement, FGFR3-related skeletal dysplasia and disorders of bone mineralisation were most frequent in this cohort. We expand the phenotypic and genotypic spectrum of rarely reported conditions (RAB33B, TRIP11, NEPRO, RPL13, COL27A1, PTHR1, EXOC6B, PRKACA, FUZ and RSPRY1) and noted novel gene-disease relationships for PISD, BNIP1, TONSL, CCN2 and SCUBE3 related skeletal dysplasia. We successfully implemented genomic testing for skeletal dysplasia in clinical and research settings. Our study provides valuable information on the spectrum of skeletal dysplasia and disease-causing variants for Asian Indians.
骨骼发育不良是一组临床和遗传上异质性的罕见疾病。来自大型队列的研究对于深入了解疾病流行病学、表型谱和突变谱至关重要。在此,我们继早期的一项类似研究之后,对来自197个患有骨骼发育不良家庭的另外248名印度人进行了统计。我们通过对37个家庭进行靶向分析以及对108个家庭进行二代测序(外显子组和基因组测序),在145个家庭中实现了临床分子诊断,诊断率为73.6%(197个家庭中的145个)。我们在73个基因中鉴定出149个致病变异,其中85个是新发现的。观察到81种不同的单基因形式的骨骼发育不良,其中常染色体隐性骨骼发育不良比例较高(60%,84个家庭)。我们在35%的家庭中观察到近亲结婚现象。在这个队列中,伴有骨骼受累的溶酶体贮积病、FGFR3相关骨骼发育不良和骨矿化障碍最为常见。我们扩展了罕见报道疾病(RAB33B、TRIP11、NEPRO、RPL13、COL27A1、PTHR1、EXOC6B、PRKACA、FUZ和RSPRY1)的表型和基因型谱,并发现了与PISD、BNIP1、TONSL、CCN2和SCUBE3相关的骨骼发育不良的新基因-疾病关系。我们在临床和研究环境中成功实施了针对骨骼发育不良的基因组检测。我们的研究为亚洲印度人的骨骼发育不良谱和致病变异提供了有价值的信息。